Spark Therapeutics, Inc.: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2018)
- $64.7M
- Net Income/Loss (FY2018)
- -$78.8M
- Total Assets (FY2018)
- $814.4M
- Total Equity (FY2018)
- $496.5M
- Cash Flows from Operating Activities (FY2018)
- -$70.6M
Source: Spark Therapeutics, Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
